Posters

Central serous chorioretinopathy treatment with eplerenone and spironolactone: A challenging case

Poster Details

First Author: S.Engur Goktas TURKEY

Co Author(s):    T. Celik                             

Abstract Details



Purpose:

To present a case of central serous chorioretinopathy (CSC) treatment with eplerenone and spironolactone in a challenge pattern.

Setting:

A 33-year-old male accountant presenting with CSC. The patient had been treated by initial medical therapy (oral carbonic anhydrase inhibitor, oral antihistamines, systemic/topical non-steroidal anti-inflammatory drugs and selective serotonin re-uptake inhibitor) and micropulse laser treatment.

Methods:

At presentation the best corrected visual acuities (BCVA) of the right and left eyes were 1.0/0.1, respectively. Optical coherence tomography (OCT) was performed on both eyes. The patient was prescribed 25 mg eplerenone daily for 8 weeks and subsequently spirinolactone 50mg for 4 weeks along with serum potassium monitoring. At follow-ups, OCT was performed.

Results:

Eplerenone and spironolactone treatment resolved the CSC. The final BCVA of the right and left eyes were 1.0/1.0, respectively. The CSC did not repeat after discontinuation the treatment. CSC totally resolved.

Conclusions:

Eplerenone and spironolactone therapy was an effective treatment of CSC in this case.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy